Purchases and Sales Made in Q1 2023 in Rubius Therapeutics, Inc. (RUBY)
This table provides information about the institutional ownership of Rubius Therapeutics, Inc. (RUBY) during Q1 2023. The information is specifically focused on institutions that hold shares of Rubius Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 15, 2023
Q1 2023
|
Baader Bank Aktiengesellschaft
Unterschleissheim, 2M |
BUY
|
- |
73.4KNew |
$1.47K - $25K
|
73.4K
$0
|
|
Apr 27, 2023
Q1 2023
|
Simplex Trading, LLC
|
BUY
|
- |
3.86KNew |
$77.1 - $1.31K
|
3.86K
$0
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Jul 17, 2024
Q1 2023
|
Kelly Financial Services LLC
Braintree, MA |
SELL
|
- |
-100Closed |
$2 - $34
|
0
$0
|
|
May 15, 2023
Q1 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-148KClosed |
$2.96K - $50.2K
|
0
$0
|
|
May 11, 2023
Q1 2023
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-1.1M- 85.93% |
$22K - $373K
|
180K
$0
|